Vascular BioSciences - Product Pipeline Analysis, 2023 Update


Vascular BioSciences (VBS) is a biopharmaceutical and medical device company that provides solutions for the treatment of cardiovascular and inflammatory diseases. The company is engaged in pharmaceutical, interventional and molecular diagnostics businesses. Its pharmaceuticals therapies address the fundamental mechanisms and pathways underlying vascular based diseases. VBS develops and manufactures endoarterial biopsy catheter for diagnosis, monitoring and treatment of vascular-based diseases. The company offers its services in the therapeutic areas of wound healing, sepsis, pulmonary hypertension, sepsis and corona disease. VBS is headquartered in Durham, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Vascular BioSciences
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Vascular BioSciences Company Overview
Vascular BioSciences Company Snapshot
Vascular BioSciences Pipeline Products and Ongoing Clinical Trials Overview
Vascular BioSciences – Pipeline Analysis Overview
Vascular BioSciences - Key Facts
Vascular BioSciences - Major Products and Services
Vascular BioSciences Pipeline Products by Development Stage
Vascular BioSciences Pipeline Products Overview
EABx - COVID-19 Product Overview
EABx - Lung Transplant Rejection
EABx - Lung Transplant Rejection Product Overview
EABx - Pulmonary Arterial Hypertension
EABx - Pulmonary Arterial Hypertension Product Overview
Imaging Agent - COVID-19
Imaging Agent - COVID-19 Product Overview
Imaging Agent - Pulmonary Hypertension
Imaging Agent - Pulmonary Hypertension Product Overview
Imaging Agent - Sepsis
Imaging Agent - Sepsis Product Overview
Vascular BioSciences - Key Competitors
Vascular BioSciences - Key Employees
Vascular BioSciences - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Vascular BioSciences, Recent Developments
Jun 03, 2020: Vascular Biosciences announces new preclinical research results demonstrating improved pulmonary hypertension and sepsis survival with car peptide
Sep 03, 2019: FDA grants Vascular BioSciences humanitarian use device (HUD) designation to the endoarterial biopsy catheter for group 1 pulmonary arterial hypertension
May 19, 2017: Vascular BioSciences Announces Publication of “Assessment of microRNA and gene dysregulaton in pulmonary hypertension by endoarterial biopsy” in the Current Issue of Pulmonary Circulation
Apr 10, 2013: Vascular BioSciences announces publication of “Vascular Histomolecular Analysis By Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension” in the Current Issue of Pulmonary Circulation
Jul 03, 2012: Vascular BioSciences announced that Dr. Kalju Kahn, PhD, has been named head of Medicinal Chemistry
Jun 27, 2011: Vascular Biosciences announces publication of “Hemodynamic and Histologic Characterization of a Swine (Sus scrofa domestica) Model of Chronic Pulmonary Arterial Hypertension”
Apr 23, 2011: Vascular BioSciences to Sponsor 2011 Southern California Undergraduate Research Conference in Chemistry and Biochemistry
Dec 24, 2010: Vascular BioSciences, In Collaboration with the University of South Alabama, Awarded Exploration/Development R21 Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Cell-targeted Drug Delivery for the Treatment of Pulmonary Arterial Hypertension (PAH)
Jan 08, 2010: Vascular BioSciences Opens New Office and Pilot Catheter Manufacturing Facility in Goleta, California
Feb 18, 2009: Vascular BioSciences CEO David Mann Awarded New U.S. and European Patents for Endorterial Biopsy Catheterization Equipment Kit Invention
About GlobalData
Contact Us
List of Tables
Table 1: Vascular BioSciences Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Vascular BioSciences Pipeline Products by Equipment Type
Table 3: Vascular BioSciences Pipeline Products by Indication
Table 4: Vascular BioSciences, Key Facts
Table 5: Vascular BioSciences, Major Products and Services
Table 6: Vascular BioSciences Number of Pipeline Products by Development Stage
Table 7: Vascular BioSciences Pipeline Products Summary by Development Stage
Table 8: EABx - COVID-19 - Product Status
Table 9: EABx - COVID-19 - Product Description
Table 10: EABx - Lung Transplant Rejection - Product Status
Table 11: EABx - Lung Transplant Rejection - Product Description
Table 12: EABx - Pulmonary Arterial Hypertension - Product Status
Table 13: EABx - Pulmonary Arterial Hypertension - Product Description
Table 14: Imaging Agent - COVID-19 - Product Status
Table 15: Imaging Agent - COVID-19 - Product Description
Table 16: Imaging Agent - Pulmonary Hypertension - Product Status
Table 17: Imaging Agent - Pulmonary Hypertension - Product Description
Table 18: Imaging Agent - Sepsis - Product Status
Table 19: Imaging Agent - Sepsis - Product Description
Table 20: Vascular BioSciences, Key Employees
Table 21: Vascular BioSciences, Other Locations
Table 22: Glossary
List of Figures
Figure 1: Vascular BioSciences Pipeline Products by Equipment Type
Figure 2: Vascular BioSciences Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings